Carregant...
Gene Mutations in Lung Cancer: Promising Predictive Factors for the Success of Molecular Therapy
Gefitinib and erlotinib are two new treatments for advanced lung cancer. Gene mutations in the cancer may help predict which patients will respond to these treatments
Guardat en:
Autors principals: | , |
---|---|
Format: | Artigo |
Idioma: | Inglês |
Publicat: |
Public Library of Science
2005
|
Matèries: | |
Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC545205/ https://ncbi.nlm.nih.gov/pubmed/15696203 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pmed.0020013 |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|